Category: RSV
-
GSK slides 6% after US CDC narrows scope of RSV shots By Reuters
•
Investor Empires(Reuters) – GlaxoSmithKline shares fell more than 6% on Thursday, a day after the U.S. public health agency narrowed its recommendation for the use of all respiratory syncytial virus (RSV) vaccines and suspended recommending their use in people under 60. The US Centers for Disease Control and Prevention (CDC) said…